Kam Kalantar-Zadeh, a specialist in internal medicine, nephrology and pediatrics at UC Irvine … was in South Korea for a conference in February. The differences between the responses in that country and the United States were stark. … “It’s terrible that this is happening in the country that’s supposed to be at the forefront of medicine.” … A proposal for human subjects research has been submitted to UC Irvine’s Institutional Review Board. If approval is granted, a notice will be posted at https://uci.edu/coronavirus/ in coming days. “Then we hope that we’ll be able to test sera from people who would like to get their blood tested for coronavirus antibodies,” said Philip L. Felgner, director of UC Irvine’s Vaccine Research and Development Center and Protein Microarray Laboratory and Training Facility. “This activity doesn’t require FDA approval. We need to anticipate more demand for this type of service,” he said.